Symbol: |
RPL13AP20
|
Description: |
null
|
Location: |
null
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:124
Gene |
Compound |
Gen_sig |
Exp_pattern |
RPL13AP20 |
NSC 303769 |
0.044 |
Up |
RPL13AP20 |
CHALCONE ANALOG |
0.043 |
Down |
RPL13AP20 |
Indeno[1,2-c]isoquinoline-5,11-dione, 6-methyl- 5-(methylsulfonyloxy)-5,6,6a,11a-tetrahydro- 2,3,8-trimethoxy-, cis- |
0.028 |
Up |
RPL13AP20 |
NSC 408470 |
0.018 |
Down |
RPL13AP20 |
NSC 41274 |
0.014 |
Up |
RPL13AP20 |
2H-1,3,5-Thiadiazine-2-thione, 3,5-diethyltetrahydro- |
0.016 |
Up |
RPL13AP20 |
NSC 50567 |
0.036 |
Down |
RPL13AP20 |
C.I. 37559 |
0.006 |
Up |
RPL13AP20 |
Camptothecin hemisuccinate sodium salt |
0.03 |
Up |
RPL13AP20 |
4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride |
0.022 |
Up |
RPL13AP20 |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.036 |
Up |
RPL13AP20 |
Oxalic acid, mono(4,9-dihydro-4,9-dioxonaphtho[2,3-d] thiazol-2-yl)hydrazide, monoethyl ester |
0.048 |
Up |
RPL13AP20 |
1,4-BIS(DIETHYLAMINO)-5,8-DIHYDROXY ANTHRAQUINON |
0.017 |
Up |
RPL13AP20 |
NSC 651668 |
0.038 |
Up |
RPL13AP20 |
NSC 657002 |
0.008 |
Up |
Expression pattern: Sensitivity / Resistance
Total:9 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:null
SNP |
Gene |
SNP_location |
SNP_allele |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:null
Gene |
Gen_transcript |
miRNA |
miR_location |
Total:0 Current:1
[First] [Prev] [Next] [Last]
|